Welcome to visit Hefei Kangchuntang Pharmaceutical Co., Ltd!

中文版 中文版  |   英文版 英文版
Manager
OA Login

Contact Us

Hefei Kangchuntang Pharmaceutical Co., Ltd.
Address: No.13, Branch Road, Biomedical Park, High-tech Zone, Hefei City, Anhui Province
Telephone:86551-63830999/63673366

Notice on Improving Technical Specifications and Financial Management of "Internet + Medical Services" Projects in Public Medical Institutions

2020-05-15 09:52

To thoroughly implement the important instructions of General Secretary Xi Jinping on coordinating epidemic prevention and control with economic and social development, and in accordance with the relevant requirements of related documents, we will further leverage the advantages of "Internet + medical services" in epidemic prevention and control, regulate the Price behavior of medical institutions' "Internet + medical services", protect the legitimate rights and interests of patients and medical institutions, improve financial management, and promote the long-term development of the new "Internet + medical services" model.

Notice on the 2020 Annual GMP Compliance Inspection of Pharmaceutical Production

2020-05-08 09:25

In accordance with the "Regulations on the Supervision and Administration of Drug Production", the "Good Manufacturing Practice for Drugs (2010 Revision)", and the Anhui Provincial Drug Supervision and Administration Bureau's "Notice on Issuing the 2020 Provincial Work Plan and Relevant Work Arrangements for the Supervision and Inspection of Drugs, Cosmetics, and Medical Devices" (皖药监办秘〔2020〕44号), the Provincial Drug Evaluation and Inspection Center, commissioned by the Provincial Bureau, conducts GMP compliance inspections on pharmaceutical companies whose GMP certificates have expired.

Notice on the Announcement of Results of Price Reductions for Certain Drugs in the Joint Procurement Program in Alliance Regions (Anhui Province)

2020-04-24 09:42

According to the Notice on the Launch of Concerted Price Reduction Work for Drugs Included in the Regional (Anhui Province) Joint Procurement of Medicines (Yao Cai [2020] No. 5), some drugs related to the regional (Anhui Province) joint procurement of medicines have applied for concerted Price reductions. The Price reduction results (see attachment for details) are hereby announced. Please promptly adjust the Prices of relevant drugs in various medical institutions.

National Medical Products Administration Announcement on the Release of the Reference Drug List for Generic Drugs (25th Batch) (No. 26, 2020)

2020-04-17 11:20

The National Medical Products Administration's Generic Drug Quality and Efficacy Consistency Evaluation Expert Committee has reviewed and determined the list of reference preparations for generic drugs (25th batch), which is now released.

Notice on Issuing Technical Guidelines for COVID-19 Prevention and Control in Key Venues, Key Units, and Key Groups

2020-04-10 10:05

Joint Prevention and Control Mechanisms (Leading Groups, Command Centers) of Novel Coronavirus Pneumonia Epidemic Prevention and Control in Provinces, Autonomous Regions, Municipalities Directly Under the Central Government, and Xinjiang Production and Construction Corps: In order to implement the decisions and deployments of the CPC Central Committee and the State Council, effectively prevent the occurrence of clustered outbreaks, minimize epidemic risks, and promote the orderly restoration of normal production and life order, we have further formulated and improved the technical guidelines for the prevention and control of key places, key units, and key groups. These guidelines are now being issued to you for your reference and implementation.

Methods for Supervision and Management of Drug Production

2020-04-01 09:20

National Market Supervision Administration Order No. 28—The Measures for the Supervision and Administration of Drug Production were adopted at the first 2020 meeting of the National Market Supervision Administration on January 15, 2020, and are hereby promulgated and shall come into effect on July 1, 2020.

Regulations on Drug Registration Management

2020-04-01 09:19

National Market Supervision Administration Order No. 27—The "Regulations on Drug Registration Management" was adopted at the 1st Bureau Meeting of the National Market Supervision Administration on January 15, 2020, and is hereby promulgated and shall come into force on July 1, 2020.

Notice of the Office of the National Health Commission on the Comprehensive and Orderly Prevention and Vaccination Work of COVID-19

2020-03-20 10:22

To guide localities in carrying out vaccination safely and promptly according to changes in the epidemic situation, and to effectively and scientifically implement vaccination work for the prevention and control of infectious diseases, the following requirements are put forward for the comprehensive and orderly implementation of vaccination work under the current circumstances

Notice on Issuing Guidelines for the Public on the Scientific Wearing of Masks

2020-03-20 10:21

Based on the current epidemic prevention and control situation and the need to comprehensively and orderly restore normal production and life order, we have compiled the "Guidelines for the Scientific Wearing of Masks by the Public". This guideline classifies people into ordinary public, personnel in specific places, key personnel, and occupationally exposed personnel, and puts forward scientific suggestions on wearing masks in different scenarios.

Notice of the Office of the National Health Commission on the Issuance of the Prevention and Control Scheme for Novel Coronavirus Pneumonia (Sixth Edition)

2020-03-11 13:53

Notice of the Office of the National Health Commission on the Issuance of the Prevention and Control Scheme for Novel Coronavirus Pneumonia (Sixth Edition)

< 123456 >